Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Veracyte Inc
Veracyte Inc logo

VCYT - Veracyte Inc Share News

$47.51 0.6  1.3%

Last Trade - 05/03/21

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Style Neutral
Market Cap £2.30bn
Enterprise Value £2.05bn
Revenue £84.9m
Position in Universe 1764th / 6651
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions VCYT Dividends
All News
All News Reuters News Company Announcements
BRIEF-Veracyte - Noridian Healthcare Solutions issues draft local coverage determination
8th Sep '16 News
BRIEF-Veracyte sees 2016 revenue $59 million to $63 million
3rd Aug '16 News
BRIEF-Veracyte CFO Shelly Guyer resigns
13th Jun '16 News
BRIEF-Veracyte announces data on role of gene alterations in thyroid cancer diagnosis
27th May '16 News
BRIEF-Veracyte reports Q1 loss per share $0.36
5th May '16 News
BRIEF-Veracyte says selling stockholders may sell up to 4.9 mln shares of co's common stock
23rd Mar '16 News
BRIEF-Veracyte Q4 loss per share $0.29
10th Mar '16 News
In grips of the bear, some small company stocks start to attract
11th Feb '16 News
BRIEF-Veracyte receives regulatory authorization to offer Percepta(TM) bronchial genomic classifier for patients in New York state
28th Jan '16 News
BRIEF-Veracyte announces expansion to new South San Francisco facility
7th Jan '16 News
BRIEF-Jaguar Animal Health appoints Karen Wright as chief financial officer
16th Dec '15 News
BRIEF-Veracyte announces positive coverage policy for the afirma gene expression classifier from health care service corporation (HCSC)
14th Dec '15 News
BRIEF-Veracyte enters consent,second amendment to loan,security agreement with Silicon Valley bank
24th Nov '15 News
BRIEF-Veracyte says new data on advancing IPF program presented today at PFF summit
12th Nov '15 News
BRIEF-Veracyte posts Q3 loss $0.32/shr
5th Nov '15 News
BRIEF-Two new studies demonstrate the long-term clinical utility of veracyte's afirma gene expression classifier in safely reducing unnecessary thyroid surgeries
21st Oct '15 News
BRIEF-Veracyte CEO urges CMS to reverse 2016 pricing for advanced molecular diagnostic tests
19th Oct '15 News
BRIEF-Veracyte says to present data from multiple Afirma GEC studies
16th Oct '15 News
BRIEF-Veracyte new American Thyroid Association guidelines recommends Veracyte's afirma gene expression classifier
15th Oct '15 News
BRIEF-Veracyte issues statement on CMS's preliminary 2016 clinical laboratory fee schedule and proposed pama rule
28th Sep '15 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.